Market revenue in 2023 | USD 10.9 million |
Market revenue in 2030 | USD 18.6 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 45.87% in 2023. Horizon Databook has segmented the Japan cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
Japan was the largest market in Asia Pacific region in 2017, primarily due to aging population, which is more susceptible to chronic diseases, presence of robust healthcare infrastructure, and high per capita income. Owing to serious health concerns among the prosperous geriatric population, the market is expected to grow at a lucrative rate over the forecast period. According to Japan Statistics Bureau, the elderly population in Japan has increased four times to reach 33.0 million in 2014, accounting for 26% of Japan’s population, which reached 33.4 million and constituted 26.7% of the total population (127.1 million) in 2015.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account